Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial

Autor: Alumkal, Joshi J., Chowdhury, Simon, Loriot, Yohann, Sternberg, Cora N., de Bono, Johann S., Tombal, Bertrand, Carles, Joan, Flaig, Thomas W., Dorff, Tanya B., Phung, De, Forer, David, Noonberg, Sarah B., Mansbach, Hank, Beer, Tomasz M., Higano, Celestia S.
Zdroj: In Clinical Genitourinary Cancer October 2017 15(5):610-617
Databáze: ScienceDirect